Meiotic and mitotic aneuploidies drive arrest of in vitro fertilized human preimplantation embryos.


Journal

Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844

Informations de publication

Date de publication:
02 10 2023
Historique:
received: 14 12 2022
accepted: 12 09 2023
medline: 4 10 2023
pubmed: 2 10 2023
entrez: 1 10 2023
Statut: epublish

Résumé

The high incidence of aneuploidy in early human development, arising either from errors in meiosis or postzygotic mitosis, is the primary cause of pregnancy loss, miscarriage, and stillbirth following natural conception as well as in vitro fertilization (IVF). Preimplantation genetic testing for aneuploidy (PGT-A) has confirmed the prevalence of meiotic and mitotic aneuploidies among blastocyst-stage IVF embryos that are candidates for transfer. However, only about half of normally fertilized embryos develop to the blastocyst stage in vitro, while the others arrest at cleavage to late morula or early blastocyst stages. To achieve a more complete view of the impacts of aneuploidy, we applied low-coverage sequencing-based PGT-A to a large series (n = 909) of arrested embryos and trophectoderm biopsies. We then correlated observed aneuploidies with abnormalities of the first two cleavage divisions using time-lapse imaging (n = 843). The combined incidence of meiotic and mitotic aneuploidies was strongly associated with blastocyst morphological grading, with the proportion ranging from 20 to 90% for the highest to lowest grades, respectively. In contrast, the incidence of aneuploidy among arrested embryos was exceptionally high (94%), dominated by mitotic aneuploidies affecting multiple chromosomes. In turn, these mitotic aneuploidies were strongly associated with abnormal cleavage divisions, such that 51% of abnormally dividing embryos possessed mitotic aneuploidies compared to only 23% of normally dividing embryos. We conclude that the combination of meiotic and mitotic aneuploidies drives arrest of human embryos in vitro, as development increasingly relies on embryonic gene expression at the blastocyst stage.

Sections du résumé

BACKGROUND
The high incidence of aneuploidy in early human development, arising either from errors in meiosis or postzygotic mitosis, is the primary cause of pregnancy loss, miscarriage, and stillbirth following natural conception as well as in vitro fertilization (IVF). Preimplantation genetic testing for aneuploidy (PGT-A) has confirmed the prevalence of meiotic and mitotic aneuploidies among blastocyst-stage IVF embryos that are candidates for transfer. However, only about half of normally fertilized embryos develop to the blastocyst stage in vitro, while the others arrest at cleavage to late morula or early blastocyst stages.
METHODS
To achieve a more complete view of the impacts of aneuploidy, we applied low-coverage sequencing-based PGT-A to a large series (n = 909) of arrested embryos and trophectoderm biopsies. We then correlated observed aneuploidies with abnormalities of the first two cleavage divisions using time-lapse imaging (n = 843).
RESULTS
The combined incidence of meiotic and mitotic aneuploidies was strongly associated with blastocyst morphological grading, with the proportion ranging from 20 to 90% for the highest to lowest grades, respectively. In contrast, the incidence of aneuploidy among arrested embryos was exceptionally high (94%), dominated by mitotic aneuploidies affecting multiple chromosomes. In turn, these mitotic aneuploidies were strongly associated with abnormal cleavage divisions, such that 51% of abnormally dividing embryos possessed mitotic aneuploidies compared to only 23% of normally dividing embryos.
CONCLUSIONS
We conclude that the combination of meiotic and mitotic aneuploidies drives arrest of human embryos in vitro, as development increasingly relies on embryonic gene expression at the blastocyst stage.

Identifiants

pubmed: 37779206
doi: 10.1186/s13073-023-01231-1
pii: 10.1186/s13073-023-01231-1
pmc: PMC10544495
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM133747
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35GM133747
Pays : United States

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Genome Res. 2020 Jun;30(6):814-825
pubmed: 32641298
J Ovarian Res. 2014 Jun 13;7:65
pubmed: 24955133
Mol Syst Biol. 2012;8:608
pubmed: 22968442
Nat Commun. 2022 Jul 25;13(1):4312
pubmed: 35879308
Sci Rep. 2017 Aug 29;7(1):9744
pubmed: 28851957
Fertil Steril. 2016 May;105(5):1215-1221
pubmed: 26826274
Hum Reprod Update. 2014 Sep-Oct;20(5):632-40
pubmed: 24795173
Nat Struct Mol Biol. 2013 Sep;20(9):1131-9
pubmed: 23934149
Biology (Basel). 2017 Feb 08;6(1):
pubmed: 28208750
Semin Cell Dev Biol. 2022 Nov;131:14-24
pubmed: 35094946
Int J Mol Sci. 2021 Aug 03;22(15):
pubmed: 34361119
Nucleic Acids Res. 2022 Jun 24;50(11):e63
pubmed: 35212381
Eur J Med Genet. 2020 Feb;63(2):103651
pubmed: 30995534
J Cell Biol. 2021 Nov 1;220(11):
pubmed: 34550316
Genes Dev. 2019 Aug 1;33(15-16):1031-1047
pubmed: 31196865
Genome Res. 2019 Oct;29(10):1705-1718
pubmed: 31548358
Nat Med. 2009 May;15(5):577-83
pubmed: 19396175
Development. 1987 Dec;101(4):777-91
pubmed: 2460303
Hum Fertil (Camb). 2020 Dec;23(4):256-267
pubmed: 30614321
Hum Reprod. 2019 Jan 01;34(1):181-192
pubmed: 30418565
Fertil Steril. 2018 Aug;110(3):351-352
pubmed: 30098681
Fertil Steril. 2014 Mar;101(3):656-663.e1
pubmed: 24355045
Trends Genet. 2017 Jul;33(7):448-463
pubmed: 28457629
Reprod Biomed Online. 2017 Feb;34(2):203-210
pubmed: 27913136
Obstet Gynecol. 2014 Aug;124(2 Pt 1):202-209
pubmed: 25004334
Adv Exp Med Biol. 2015;843:77-128
pubmed: 25956296
Fertil Steril. 2008 Sep;90(3):473-83
pubmed: 18847602
Fertil Steril. 2018 Aug;110(3):353-361
pubmed: 30098682
Acta Histochem. 2015 Jan;117(1):111-25
pubmed: 25554607
Nat Rev Genet. 2012 Jun 18;13(7):493-504
pubmed: 22705668
PLoS Genet. 2015 Oct 22;11(10):e1005601
pubmed: 26491874
J Assist Reprod Genet. 2016 Oct;33(10):1261-1272
pubmed: 27491772
Cell. 2022 Aug 4;185(16):2988-3007.e20
pubmed: 35858625
Nature. 2019 Jun;570(7759):117-121
pubmed: 31068692
Nat Commun. 2015 Jul 07;6:7601
pubmed: 26151134
Hum Reprod. 1993 Dec;8(12):2185-91
pubmed: 8150922
Reprod Biomed Online. 2013 May;26(5):477-85
pubmed: 23518033
Int J Fertil Steril. 2015 Oct-Dec;9(3):346-53
pubmed: 26644858
Hum Reprod. 2023 Feb 1;38(2):315-323
pubmed: 36610460
Baillieres Clin Obstet Gynaecol. 1991 Mar;5(1):179-89
pubmed: 1855339
Nature. 2022 Sep;609(7928):683-684
pubmed: 36114306
Nat Rev Genet. 2013 May;14(5):307-20
pubmed: 23594909
Nat Commun. 2016 Mar 29;7:11165
pubmed: 27021558
Reprod Med Biol. 2019 Nov 21;19(1):3-12
pubmed: 31956280
Hum Reprod. 2014 Jun;29(6):1173-81
pubmed: 24578475
Hum Reprod Update. 2002 Jul-Aug;8(4):333-43
pubmed: 12206468
Reprod Sci. 2022 May;29(5):1597-1607
pubmed: 35304731
Nature. 1988 Mar 31;332(6163):459-61
pubmed: 3352746
Hum Reprod. 2011 Jun;26(6):1270-83
pubmed: 21502182
Prenat Diagn. 2021 Apr;41(5):525-535
pubmed: 32833230
Mol Hum Reprod. 2022 Apr 1;28(4):
pubmed: 35404421
Hum Reprod Update. 2021 Aug 20;27(5):848-865
pubmed: 34131722
Hum Fertil (Camb). 2013 Dec;16(4):278-85
pubmed: 23862646
Hum Reprod. 2014 Dec;29(12):2650-60
pubmed: 25344070
Nat Cell Biol. 2021 Apr;23(4):314-321
pubmed: 33837289
Cell. 2021 May 27;184(11):2860-2877.e22
pubmed: 33964210
Dev Cell. 2018 Feb 26;44(4):420-431
pubmed: 29486194
Fertil Steril. 2019 May;111(5):991-1001.e2
pubmed: 30922649
Sci Rep. 2018 Oct 8;8(1):14906
pubmed: 30297919
Reprod Biomed Online. 2021 May;42(5):892-900
pubmed: 33810985
Fertil Steril. 2014 Aug;102(2):394-8
pubmed: 24890269
Am J Hum Genet. 2021 Dec 2;108(12):2238-2247
pubmed: 34798051
Nat Rev Mol Cell Biol. 2022 Apr;23(4):250-265
pubmed: 34987171
Science. 2018 Jul 13;361(6398):189-193
pubmed: 30002254
Science. 2007 Aug 17;317(5840):916-24
pubmed: 17702937
Nat Commun. 2022 Nov 8;13(1):6755
pubmed: 36347869
NPJ Genom Med. 2021 Oct 7;6(1):81
pubmed: 34620870
Cell. 2022 Aug 4;185(16):3041-3055.e25
pubmed: 35917817
Reproduction. 2016 Dec;152(6):R247-R261
pubmed: 27601713
Hum Reprod. 2014 Dec;29(12):2802-13
pubmed: 25336713
J Community Genet. 2018 Oct;9(4):377-386
pubmed: 28948513
Hum Genet. 2013 Sep;132(9):1001-13
pubmed: 23620267
Reprod Biomed Online. 2017 Feb;34(2):137-146
pubmed: 27938863
Fertil Steril. 2012 Dec;98(6):1458-63
pubmed: 22925687
Development. 2015 Sep 15;142(18):3151-65
pubmed: 26293300
Hum Reprod Update. 2003 Nov-Dec;9(6):557-82
pubmed: 14714592
Nat Commun. 2020 Jun 11;11(1):2958
pubmed: 32528010
Fertil Steril. 2023 Nov;120(5):957-966
pubmed: 37532168

Auteurs

Rajiv C McCoy (RC)

Department of Biology, Johns Hopkins University, 3400 N. Charles Street, Baltimore, MD, 21212, USA. rajiv.mccoy@jhu.edu.

Michael C Summers (MC)

London Women's Clinic, 113-115 Harley Street, Marylebone, London, W1G 6AP, UK.
School of Biosciences, University of Kent, Canterbury, CT2 7NJ, Kent, UK.
Present Address: London Women's Clinic, The Chesterfield, Nuffield Health Clinic, 3 Clifton Hill, Bristol, BS8 1BN, UK.

Abeo McCollin (A)

London Women's Clinic, 113-115 Harley Street, Marylebone, London, W1G 6AP, UK.
School of Biosciences, University of Kent, Canterbury, CT2 7NJ, Kent, UK.

Christian S Ottolini (CS)

London Women's Clinic, 113-115 Harley Street, Marylebone, London, W1G 6AP, UK.
Department of Maternal and Fetal Medicine, University College London, 86-96 Chenies Mews, London, WC1E 6HX, UK.
Present Address: Juno Genetics Italia, Via Di Quarto Peperino 22, 00188, Rome, Italy.

Kamal Ahuja (K)

London Women's Clinic, 113-115 Harley Street, Marylebone, London, W1G 6AP, UK.

Alan H Handyside (AH)

School of Biosciences, University of Kent, Canterbury, CT2 7NJ, Kent, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH